The Effect of Pancreastatin on Endocrine and Exocrine Pancreas

References

• Tatemoto K, Efendic S, Mutt V, Makk G, Feistner G J, Barchas J D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476–478
   PubMed Web of Science ®Google Scholar
• Ravazzola M, Efendic S, Ostenson C G, Tatemoto K, Hutton J C, Orci L. Localization of pancreastatin immunoreactivity in porcine endocrine cells. Endocrinology 1988; 123: 227–229
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Siegel E G, Lamberts R, Gallwitz B, Creutzfeldt W. Pancreastatin: molecular and im munocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988; 123: 1395–1404
   PubMed Web of Science ®Google Scholar
• Bretherton‐Watt D, Ghatei M A, Bishop A E, et al. Pancreastatin distribution and plasma levels in the pig. Peptides 1988; 9: 1005–1014
   PubMed Web of Science ®Google Scholar
• Bishop A E, Bretherton‐Watt D, Hamid Q A, et al. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system. Mol Cell Probes 1988; 2: 225–235
   PubMed Web of Science ®Google Scholar
• Tateishi K, Funakoshi A, Jimi A, et al. High plasma pancreastatin–like immunoreactivity in a patient with malignant insulinoma. Gastroenterology 1989; 97: 1313–1318
   PubMed Web of Science ®Google Scholar
• Sekiya K, Ghatei M A, Minamino N, Watt Bretherton D, Matsuo H, Bloom S R. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma. FEBS Lett 1988; 228: 153–156
   PubMed Web of Science ®Google Scholar
• Cohn D V, Elting J J, Frick M, Elde R. Selective localization of the parathyroid secretory protein‐1/ adrenal medulla chromogranin A protein family in a wide variety of endocrine cells of the rat. Endocrinology 1984; 114: 1963–1974
   PubMedGoogle Scholar
• Wilson B S, Lloyd R V. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984; 115: 458–468
   PubMed Web of Science ®Google Scholar
• Iacangelo A, Affolter H ‐U, Eiden L E, Herbert E, Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 1986; 323: 82–86
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Siegel E G, Kratzin H, Creutzfeldt W. Isolation and primary structure of tumor‐derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci 1988; 85: 8231–8235
   PubMed Web of Science ®Google Scholar
• Eiden L E. Is chromogranin a prohormone?. Nature 1987; 325: 301
   PubMed Web of Science ®Google Scholar
• Konecki D S, Benedum U M, Gerdes H H, Huttner W B. The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987; 262: 17026–17030
   PubMed Web of Science ®Google Scholar
• Iacangelo A L, Fischer‐Colbrie R, Koller K J, Brownstein M J, Eiden L E. The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 1988; 122: 2339–2341
   PubMed Web of Science ®Google Scholar
• Greeley G H, Thompson J C, Ishizuka J, et al. Inhibition of glucose stimulated insulin release in the perfused rat pancreas by parathyroid secretory protein‐I (chiomogranin A). Endocrinology 1989; 124: 1235–1238
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kogire M, Lluis F, et al. Stimulatory effect of pancreastatin on gastric acid secretion in conscious dogs. Gastroenterology 1990; 99: 61–65
   PubMed Web of Science ®Google Scholar
• Lewis J J, Zdon M J, Adrian T E, Modlin I M. Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 1988; 104: 1031–1036
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Poston G J, Gomez G, Tatemoto K, Greeley G H, Thompson J C. Effect of pancreastatin on cholecystokinin‐stimulated gallbladder contraction in vivo and in vitro. Gastroenterology 1988; 94: A176
   Google Scholar
• Gunion M W, Rosenthal M J, Tatemoto K, Morley J E. Intracranial microinfusion of pancreastatin elevates blood glucose, free fatty acids and cortico sterone in rats. Brain Res 1989; 485: 251–257
   PubMed Web of Science ®Google Scholar
• Flood J F, Morley J E, Tatemoto K. Effects of systemic pancreastatin on memory retention. Peptides 1988; 9: 1077–1080
   PubMed Web of Science ®Google Scholar
• Smith J P, Kramer S T. Pancreastatin inhibits growth of pancreatic cancer. Gastroenterology 1989; 96: A479
   PubMedGoogle Scholar
• Schmidt W E, Stöckmann F, Choudhury A R, et al. Influence of CCK antagonist L‐364,718, pancreastatin (33–49) and a somatostatin analogue on camostate‐induced rat pancreatic hypertrophy. Digestion 1989; 44: 105–116
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Nakamura R, et al. Bioactivity of synthetic human pancreastatin on exo crine pancreas. Biochem Biophys Res Commun 1988; 156: 1237–1242
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Nakamura R, et al. Inhibitory effect of pancreastatin on pancreatic exo crine secretion in the conscious rat. Gastroenterology 1988; 94: A138
   Google Scholar
• Funakoshi A, Miyasaka K, Nakamura R, et al. Comparative effects of mammalian pancreastatins on the pancreatic exocrine secretion. Gastroenterology 1989; 96: A163
   Google Scholar
• Herzig K H, Tatemoto K, Owyang C. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Gastroenterology 1988; 94: A184
   Google Scholar
• Miyasaka K, Funakoshi A, Yasunami Y, et al. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats. Reg Pept 1990; 28: 189–198
   PubMedGoogle Scholar
• Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Funakoshi S, Fujii N. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Gastroenterology 1990; 99: 1751–1756
   PubMedGoogle Scholar
• Miyasaka K, Funakoshi A, Nakamura R, Kitani K, Shimizu F, Tatemoto K. Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 1989; 43: 204–211
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Kitani K, Tamamura H, Funakoshi S, Yajima H. Bioactivity of synthetic C‐terminal fragment of rat pancreastatin on endocrine pancreas. Biochem Biophys Res Commun 1989; 158: 844–849
   PubMed Web of Science ®Google Scholar
• Graham S M, Zucker K A, Adrian T E, Zdon M J, Modlin I M. Pancreastatin; a novel regulatory pep‐tide which inhibits pancreatic exocrine function. Gastroenterology 1988; 94: A153
   Google Scholar
• Ishizuka J, Asada I, Poston G J, et al. Effect of pancreastatin on pancreatic endocrine and exocrine secretion. Pancreas 1989; 4: 277–281
   PubMed Web of Science ®Google Scholar
• Hoist J J, Östenson C ‐G, Harling H, Messell T. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas. Diabetologia 1990; 33: 403–406
   PubMedGoogle Scholar
• Schônfeld J, Kleimann J, Müller M K, Rünzi M, Goebell H. Glucose‐dependent effects of pancreastatin on insulin and glucagon release. Int J Pancreatol 1991, In press
   Google Scholar
• Doi R, Inoue K, Hosotani R, et al. Effect of synthetic human pancreastatin on CCK‐stimulated exocrine pancreas and pancreatic blood flow. Digestion 1990; 46(suppl 1)24
   Google Scholar
• Williams J A, Goldfine I D. The insulin‐pancreatic acinar axis. Diabetes 1985; 34: 980–986
   PubMed Web of Science ®Google Scholar
• Holst J J. Does the endocrine secretion of the pancreas exert a local control of the exocrine secretion?. Pancreas 1987; 2: 613–619
   PubMedGoogle Scholar
• Funakoshi A, Jimi A, Yasunami Y, et al. Bioactivity of human pancreastatin and its localization in pancreas. Biochem Biophys Res Commun 1989; 159: 913–918
   PubMed Web of Science ®Google Scholar
• v Schönfeld J, Müller M K, Demirtas B, Soukup J, Rünzi M, Goebell H. Effect of neural blockade on somatostatin‐induced inhibition of exocrine pancreatic secretion. Digestion 1989; 43: 81–86
   PubMedGoogle Scholar
• Ahren B, Lindskog S, Tatemoto K, Efendic S. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988; 37: 281–285
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Kitani K, Tatemoto K. Effect of pancreastatin on pancreatic endocrine function in the conscious rat. Regul Pept 1989; 24: 225–231
   PubMedGoogle Scholar
• Lindskog S, Ahren B. Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects. Hormone Res 1988; 29: 237–240
   PubMedGoogle Scholar
• Efendic S, Tatemoto K, Mutt V, Quan C, Chang D, Östenson C ‐G. Pancreastatin and islet hormone release. Proc Natl Acad Sci 1987; 84: 7257–7260
   PubMed Web of Science ®Google Scholar
• Lorinet A ‐M, Tatemoto K, Laburthe M, Amiranoff B. Pancreastatin inhibits insulin release from Rin m 5F cells: reversion by pertussis toxin. Eur J Pharmacol 1989; 160: 405–407
   PubMed Web of Science ®Google Scholar
• Peiro E, Miralles P, Silvestre R A, Villanueva M L, Marco J. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8‐cholecystokinin in the perfused rat pancreas. Metabolism 1989; 38: 679–682
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Binder G, Gallwitz B, Siegel E G, Creutzfeldt W. C‐terminal fragments of pancreastatin inhibit GIP‐induced insulin secretion in isolated rat pancreatic islets. Diabetologia 1987; 30: 579
   Web of Science ®Google Scholar
• Silvestre R A, Peiro E, Miralles P, Villanueva M L, Marco J. Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas. Life Sci 1988; 42: 1361–1367
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Tateishi K, Shinozaki H, Matsumoto M, Wakasugi H. Elevated plasma levels of pancreastatin (PST) in patients with non‐insulin‐dependent diabetes mellitus (NIDDM). Regul Pept 1990; 30: 159–164
   PubMedGoogle Scholar